论文部分内容阅读
目的探讨头孢他啶治疗老年肺心病并发肺部细菌感染的临床疗效。方法以我院收治的40例肺心病并发肺部细菌感染的老年患者作为研究对象,所有患者病情均已加剧,给予头孢他啶治疗,每日共4g,分2次静脉滴注,7-10日为1疗程。观察临床疗效、细菌清除状况、临床不良反应发生情况等,评价头孢他啶的安全性与有效性。结果 40例患者中,18例痊愈,13例显效,7例改善及2例无效,治愈率77.5%,有效率为95%,全部患者于头孢他啶治疗期间均未出现肝肾功能障碍。结论头孢他啶治疗老年肺心病并发肺部细菌感染可获取确切临床疗效,该药物安全性与有效性较优,值得推广使用。
Objective To investigate the clinical efficacy of ceftazidime in the treatment of pulmonary infection in elderly patients with pulmonary heart disease. Methods A total of 40 elderly patients with pulmonary heart disease and pulmonary bacterial infection admitted to our hospital were enrolled in this study. All patients were exacerbated and treated with ceftazidime, 4g daily, intravenous drip twice daily and 7-10 days 1 course of treatment. To observe the clinical efficacy, bacterial clearance, clinical adverse reactions, etc., to evaluate the safety and effectiveness of ceftazidime. Results Among the 40 patients, 18 were cured, 13 were markedly effective, 7 were improved and 2 were ineffective. The cure rate was 77.5% and the effective rate was 95%. No liver and kidney dysfunction occurred in all patients during the treatment with ceftazidime. Conclusion Ceftazidime treatment of pulmonary disease in elderly patients with pulmonary bacterial infection can obtain the exact clinical efficacy of the drug safety and effectiveness of better, it is worth promoting the use of.